M&A Deal Summary

Apollo Endosurgery Acquires Apollo Endosurgery

On December 29, 2016, Apollo Endosurgery acquired medical products company Apollo Endosurgery

Acquisition Highlights
  • This is Apollo Endosurgery’s 1st transaction in the Medical Products sector.
  • This is Apollo Endosurgery’s 1st transaction in the United States.
  • This is Apollo Endosurgery’s 1st transaction in Texas.

M&A Deal Summary
Date 2016-12-29
Target Apollo Endosurgery
Sector Medical Products
Buyer(s) Apollo Endosurgery
Deal Type Merger
Advisor(s) Piper Sandler & Co. (Financial)
Cooley (Legal)

Target

Apollo Endosurgery

Austin, Texas, United States
Apollo Endosurgery, Inc. (old) is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 500 million people globally, as well as other gastrointestinal disorders.

Search 201,771 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Apollo Endosurgery

Austin, Texas, United States
Category Company
Founded 2005
Sector Life Science
Employees202
Revenue 77M USD (2022)
DESCRIPTION

Apollo Endosurgery is a developer of therapeutic antibodies that bind and inhibit bioactive lipids that contribute to disease. The company concluded mid-stage clinical development of drug candidates iSONEP™ (sphingomab) in wet age-related macular degeneration and ASONEP™ (anti-S1P antibody for systemic delivery) in renal cell carcinoma in 2015. Apollo Endosurgery was incorporated in 2005 and is based in Austin, Texas.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Merger) 1 of 1
State (Texas) 1 of 1
Country (United States) 1 of 1
Year (2016) 1 of 1
Mergr

Product

Company

Legal